Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.

Bourantas LK, Pappas G, Kapsali E, Gougopoulou D, Papamichail D, Bourantas KL.

Ann Pharmacother. 2010 Oct;44(10):1677-80. doi: 10.1345/aph.1P249. Epub 2010 Sep 7.

PMID:
20823278
2.

Rituximab in steroid refractory autoimmune hemolytic anemia.

Gupta N, Sharma S, Seth T, Mishra P, Mahapatra M, Kumar S, Kapoor R, Agarwal N.

Indian J Pediatr. 2012 Jun;79(6):803-5. doi: 10.1007/s12098-011-0544-4. Epub 2011 Aug 10.

PMID:
21830023
3.

Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.

Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.

Cancer Chemother Pharmacol. 2008 Sep;62(4):741-3. Epub 2007 Dec 7.

PMID:
18064461
5.

Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.

So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B.

Mod Rheumatol. 2014 Sep;24(5):855-7. doi: 10.3109/14397595.2013.874740. Epub 2014 Feb 11.

PMID:
24517558
7.

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.

Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR; Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA.

Ann Hematol. 2010 Nov;89(11):1073-80. doi: 10.1007/s00277-010-0997-y. Epub 2010 Jun 5.

PMID:
20526716
8.

[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2013 Nov;54(11):2053-5. Japanese.

PMID:
24305538
10.

Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.

Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C.

Haematologica. 2004 Sep;89(9):ECR34.

11.

[Lower dose of rituximab in the treatment of elderly autoimmune hemolytic anemia].

Zhang X, Sun J.

Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):236-8. doi: 10.3760/cma.j.issn.0253-2727.2014.03.012. Chinese.

PMID:
24666491
12.

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.

Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, Rai KR.

Leukemia. 2002 Oct;16(10):2092-5.

13.

[Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].

Tanaka Y, Ito Y, Yoshizawa S, Fujimoto H, Gotoh M, Tauchi T, Kimura Y, Ohyashiki K.

Rinsho Ketsueki. 2013 Feb;54(2):229-31. Japanese.

PMID:
23470833
14.

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.

Dierickx D, Kentos A, Delannoy A.

Blood. 2015 May 21;125(21):3223-9. doi: 10.1182/blood-2015-01-588392. Epub 2015 Mar 31. Review.

PMID:
25827833
15.

Rituximab in patients with refractory autoimmune hemolytic anemia.

Dierickx D, Verhoef G, Delannoy A.

Ann Hematol. 2011 Aug;90(8):985-6. doi: 10.1007/s00277-010-1117-8. Epub 2010 Nov 19. No abstract available.

PMID:
21088966
16.

Rituximab for treatment of autoimmune hemolytic anemia.

Kuzmanovic M, Jurisic V.

Indian Pediatr. 2012 Aug;49(8):672-4.

18.

Successful rituximab therapy in the treatment of refractory cold haemagglutinin disease with long-term disease control.

Khalafallah A, Vos LJ, Beamish M, Rooney K.

Intern Med J. 2010 May;40(5):387-9. doi: 10.1111/j.1445-5994.2010.02173.x. No abstract available.

PMID:
20575998
19.

Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis.

Eskazan AE, Dal MS, Kaya S, Dal T, Ayyildiz O, Soysal T.

Intern Med. 2014;53(11):1153-8. Epub 2014 Jun 1. Review.

20.

Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.

Moriya K, Matsuhashi T, Onuma M, Niizuma H, Rikiishi T, Asada H, Suzuki J, Sasahara Y, Kure S.

Int J Hematol. 2013 Aug;98(2):237-9. doi: 10.1007/s12185-013-1374-0. Epub 2013 May 24.

PMID:
23702915
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk